Evidence map›Paper›PMID 39951821›Full record

ArticleThe journal of physical chemistry letters2025

The Surface of Imidazolium-Based Ionic Liquids Consists of Two Interfaces.

Helga Tóth Ugyonka, György Hantal, István Szilágyi, Abdenacer Idrissi, Miguel Jorge, Pál Jedlovszky

Abstract read
In one paragraph

Article in The journal of physical chemistry letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Helga Tóth UgyonkaDepartment of Chemistry, Eszterházy Károly Catholic University, Leányka utca 12, H-3300 Eger, Hungary.
György HantalPULS Group, Department of Physics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Cauerstr. 3, D-91058 Erlangen, Germany.ORCID 0000-0003-4678-1167
István SzilágyiMTA-SZTE Lendület Biocolloids Research Group, Department of Physical Chemistry and Materials Science, Interdisciplinary Excellence Center, University of Szeged, H-6720 Szeged, Hungary.ORCID 0000-0001-7289-0979
Abdenacer IdrissiUniversity of Lille, CNRS UMR 8516 -LASIRe - Laboratoire Avancé de Spectroscopie pour les Interactions la Réactivité et l'environnement, 59000 Lille, France.ORCID 0000-0002-6924-6434
Miguel JorgeDepartment of Chemical and Process Engineering, University of Strathclyde, 75 Montrose Street, Glasgow G1 1XJ, United Kingdom.ORCID 0000-0003-3009-4725
Pál JedlovszkyDepartment of Chemistry, Eszterházy Károly Catholic University, Leányka utca 12, H-3300 Eger, Hungary.ORCID 0000-0001-9304-435X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Room temperature ionic liquids (RTILs) are important in a myriad of applications and exhibit fascinating properties arising from a delicate interplay between their ionic and apolar groups. Here, using molecular simulations coupled with intrinsic surface analysis, we reveal how this interplay is responsible for the unique properties of the RTIL surface. Our results show that this surface can be viewed as a superposition of two "interfaces", one between a hydrophobic layer of cation alkyl chains and the vapor phase, and another between that hydrophobic layer and an ionic fluid composed of polar groups of the cations and anions. Remarkably, the properties of this ionic surface are practically independent of the cation alkyl chain length, suggesting they are a universal feature of imidazolium-based RTILs. This finding has potential implications in the selection and design of RTIL systems for separation applications, which depend on interactions between penetrant molecules and the RTIL surface.

Identifiers

PMID39951821
PMCPMC12071681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.